Qualigen Enters Into Multiple Partnering Transactions

Represented Qualigen, an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer, in partnering transactions with McKesson Corporation (NYSE: MCK), Argutus Medical Ltd, Prediction BioSciences SAS, Banyan Biomarkers, Inc., and Roka Bioscience.